Faculty180 - Vita and Individual Profile Data Sheet

Megan Trinkle-Knotts, MS, CGC

Fall 1980 - Fall 2120

[email protected]

Current Position

Position: Adjunct Faculty

Biography

Ms. Tucker is a licensed and certified genetic counselor from Indianapolis, IN. She began her career at St. Vincent Hospital working in both prenatal and pediatric practices for nearly 10 years. During that time, she helped develop a statewide Perinatal Loss Evaluation Program offering a free customized evaluation service for families experiencing a stillbirth and a Cord Blood Collection/Genetics Consultation Initiative to avoid “missed opportunities” for babies that were identified as having an anomaly or suspected life-threating complications. In 2015, she joined The Center for Genomic Advocacy at Indiana State University to establish a new Master’s in Genetic Counseling Program as well as a new Genetic Counseling Clinic focusing on oncology and psychiatric genetic counseling. She now is the Assistant Director/Fieldwork Coordinator of Genetic Counseling for Bay Path University. Ms. Tucker holds a Certificate in Leadership Development, Indiana University Purdue University, Indianapolis, IN, an M.S. Medical and Molecular Genetics from Indiana University, IN, and a B.S. in Secondary Biology Education from Indiana University, Bloomington, IN. She holds licenses from the Medical Licensing Board of Indiana and the American Board of Genetic Counseling, Inc.

Degrees

2006

M.S., Genetic Counseling, Indiana University, Indianapolis, Indiana, United States

Scholarly Contributions and Creative Productions

Journal Article

Completed/Published

Fry, Deanna, Daniel Groepper, Gretchen MacCarrick, Erin M. Demo, Matthew J. Thomas, Margaret J. Wilkes, Michael J. Lyons, M E. Tucker, Catherine Steding, and Julie Fleischer. 2022. “Loeys-Dietz Syndrome Caused by 1q41 Deletion Including TGFB2 Is Associated with a Neurodevelopmental Phenotype.” American Journal of Medical Genetics. Part A 188:2237–41.
Brooks, Kassi, Melissa Holman, Catherine Steding, and Megan Tucker. 2022. “A Founder CHEK2 Pathogenic Variant in Association with Kidney Cancer.” Cancer Genetics 262–263:40–42.